BMRA
Biomerica Inc.
Halal Rating :
Last Price
$0.65
Last updated:
Market Cap
-
7D Change
102.74%
1 Year Change
-28.47%
Company Overview
Industries
Exchange
Next Earnings Date
Biomerica, Inc. develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Nov. 30, 2024 | $1.64m | $2.63m | - | - | 0.00% | 0.00% |
| Aug. 31, 2024 | $1.81m | $3.17m | - | - | 0.00% | 0.00% |
| May 31, 2024 | $1.12m | $2.65m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Biomerica Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.